drugset / Trial / NCT00096317

Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors

NCT00096317

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as ixabepilone and ketoconazole, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving ixabepilone with ketoconazole may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of giving ixabepilone together with ketoconazole and to see how well they work in treating patients with advanced solid tumors.

Timeline

Start
2003-03
Primary completion
2005-12-05
Completion
2005-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule 25 mg/m2 Intravenous
Subject Ixabepilone Small molecule 40 mg/m2 Intravenous
Subject Ketoconazole Small molecule 400 mg Oral